Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281872020> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4281872020 endingPage "A201" @default.
- W4281872020 startingPage "A200" @default.
- W4281872020 abstract "Abstract Introduction In Phase 3 Study 304 (NCT02783729), lemborexant (LEM) provided significant benefit versus placebo (PBO) on polysomnographic (PSG) endpoints and sleep diary-based sleep onset and maintenance outcomes over 1mo in subjects with insomnia disorder. The study also included the Insomnia Severity Index (ISI) to ensure sufficient insomnia severity at baseline (ISI total score ≥13) and for use as an outcome measure. Subjects met criteria for insomnia disorder and were confirmed to spend between 7-9 hours in bed. Subjects had insomnia with objective short sleep (ISS; [total sleep time; TST] <6hrs) or objective long sleep (TST ≥6hrs). Since patients with ISS may respond less well to therapeutic approaches such as cognitive behavioral therapy for insomnia (CBT-I), we examined rates of response and remission with LEM as defined by the ISI in the ISS subgroup. Methods Study 304 was a 1mo, randomized, double-blind, PBO- and active-controlled, parallel-group study in female (age ≥55y) and male (age ≥65y) subjects (n=1006). Subjects received PBO, LEM 5mg (LEM5), LEM 10mg (LEM10), or zolpidem tartrate extended-release 6.25 mg (not reported). Baseline PSGs were obtained during a single-blind PBO run-in, followed by paired PSGs on Nights 1/2 and Nights 29/30. The ISI was given at baseline and end of treatment. For these post-hoc analyses, responders were defined as subjects whose decrease from baseline on the ISI was ≥7pts, while remitters achieved ISI total scores <8pts. LEM5 and LEM10 vs PBO differences were evaluated using chi-square tests. Results 525/743 (70.66%) of subjects in the PBO/LEM groups were in the ISS subgroup. For LEM5, 99/176 (56.25%) were responders and 49/176 (27.84%) were remitters. For LEM10, 97/180 (53.89%) were responders and 50/180 (27.78%) were remitters. For the PBO group, 59/140 (42.14%) were responders and 21/140 (15.00%) were remitters. The responder and remitter rates for LEM5 and LEM10 were statistically significantly greater than those for PBO (all P<0.05). Conclusion Older adults with ISS achieved clinically meaningful improvement with LEM as assessed at the end of one month of treatment, with nearly 30% considered remitters and >50% considered treatment responders. LEM is a potential therapy for ISS patients who may have limited response to CBT-I. Support (If Any) Eisai Inc." @default.
- W4281872020 created "2022-06-13" @default.
- W4281872020 creator A5032444617 @default.
- W4281872020 creator A5037160091 @default.
- W4281872020 creator A5041846228 @default.
- W4281872020 creator A5042168269 @default.
- W4281872020 creator A5055947439 @default.
- W4281872020 creator A5078195357 @default.
- W4281872020 date "2022-05-25" @default.
- W4281872020 modified "2023-09-25" @default.
- W4281872020 title "0452 Lemborexant Treatment of Older Adults with Insomnia and Objective Short Sleep: Rates of Response and Remission" @default.
- W4281872020 doi "https://doi.org/10.1093/sleep/zsac079.449" @default.
- W4281872020 hasPublicationYear "2022" @default.
- W4281872020 type Work @default.
- W4281872020 citedByCount "0" @default.
- W4281872020 crossrefType "journal-article" @default.
- W4281872020 hasAuthorship W4281872020A5032444617 @default.
- W4281872020 hasAuthorship W4281872020A5037160091 @default.
- W4281872020 hasAuthorship W4281872020A5041846228 @default.
- W4281872020 hasAuthorship W4281872020A5042168269 @default.
- W4281872020 hasAuthorship W4281872020A5055947439 @default.
- W4281872020 hasAuthorship W4281872020A5078195357 @default.
- W4281872020 hasBestOaLocation W42818720201 @default.
- W4281872020 hasConcept C118552586 @default.
- W4281872020 hasConcept C126322002 @default.
- W4281872020 hasConcept C142724271 @default.
- W4281872020 hasConcept C1513209611 @default.
- W4281872020 hasConcept C15744967 @default.
- W4281872020 hasConcept C1862650 @default.
- W4281872020 hasConcept C204787440 @default.
- W4281872020 hasConcept C27081682 @default.
- W4281872020 hasConcept C2777123777 @default.
- W4281872020 hasConcept C2778205975 @default.
- W4281872020 hasConcept C2778910407 @default.
- W4281872020 hasConcept C2778996325 @default.
- W4281872020 hasConcept C2781210498 @default.
- W4281872020 hasConcept C2781326671 @default.
- W4281872020 hasConcept C63759246 @default.
- W4281872020 hasConcept C67761136 @default.
- W4281872020 hasConcept C71924100 @default.
- W4281872020 hasConceptScore W4281872020C118552586 @default.
- W4281872020 hasConceptScore W4281872020C126322002 @default.
- W4281872020 hasConceptScore W4281872020C142724271 @default.
- W4281872020 hasConceptScore W4281872020C1513209611 @default.
- W4281872020 hasConceptScore W4281872020C15744967 @default.
- W4281872020 hasConceptScore W4281872020C1862650 @default.
- W4281872020 hasConceptScore W4281872020C204787440 @default.
- W4281872020 hasConceptScore W4281872020C27081682 @default.
- W4281872020 hasConceptScore W4281872020C2777123777 @default.
- W4281872020 hasConceptScore W4281872020C2778205975 @default.
- W4281872020 hasConceptScore W4281872020C2778910407 @default.
- W4281872020 hasConceptScore W4281872020C2778996325 @default.
- W4281872020 hasConceptScore W4281872020C2781210498 @default.
- W4281872020 hasConceptScore W4281872020C2781326671 @default.
- W4281872020 hasConceptScore W4281872020C63759246 @default.
- W4281872020 hasConceptScore W4281872020C67761136 @default.
- W4281872020 hasConceptScore W4281872020C71924100 @default.
- W4281872020 hasIssue "Supplement_1" @default.
- W4281872020 hasLocation W42818720201 @default.
- W4281872020 hasOpenAccess W4281872020 @default.
- W4281872020 hasPrimaryLocation W42818720201 @default.
- W4281872020 hasRelatedWork W2066436606 @default.
- W4281872020 hasRelatedWork W2119644947 @default.
- W4281872020 hasRelatedWork W2150194133 @default.
- W4281872020 hasRelatedWork W2601294772 @default.
- W4281872020 hasRelatedWork W2609575308 @default.
- W4281872020 hasRelatedWork W3032253714 @default.
- W4281872020 hasRelatedWork W3109891723 @default.
- W4281872020 hasRelatedWork W4281664686 @default.
- W4281872020 hasRelatedWork W4281872020 @default.
- W4281872020 hasRelatedWork W4310773531 @default.
- W4281872020 hasVolume "45" @default.
- W4281872020 isParatext "false" @default.
- W4281872020 isRetracted "false" @default.
- W4281872020 workType "article" @default.